H Findlow

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. doi request reprint Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, United Kingdom
    Pediatr Infect Dis J 31:616-22. 2012
  2. pmc Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, P O Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom
    Clin Vaccine Immunol 18:1492-6. 2011
  3. pmc Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults
    H Findlow
    Vaccine Evaluation Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, P O Box 209, Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom
    Clin Vaccine Immunol 18:424-9. 2011
  4. pmc Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults
    H Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, Clinical Sciences Building, Manchester Royal Infirmary, Manchester, UK
    Clin Vaccine Immunol 16:969-77. 2009
  5. pmc Competitive inhibition flow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular polysaccharide
    H Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, P O Box 209, Clinical Sciences Building, CSB2, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, United Kingdom
    Clin Vaccine Immunol 16:222-9. 2009
  6. ncbi request reprint Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, Manchester Royal Infirmary, Manchester, M13 9WZ, UK
    J Infect Dis 195:1071-7. 2007
  7. pmc Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, P O Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester, M13 9WZ, United Kingdom
    Clin Vaccine Immunol 13:507-10. 2006
  8. pmc Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom
    Jo Southern
    Immunisation Department, Centre for Infections, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Clin Vaccine Immunol 16:194-9. 2009
  9. pmc Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine
    Ray Borrow
    Vaccine Evaluation Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, P O Box 209, Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom
    Clin Vaccine Immunol 17:154-9. 2010
  10. pmc Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age
    Elizabeth Miller
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Clin Vaccine Immunol 18:367-72. 2011

Collaborators

Detail Information

Publications13

  1. doi request reprint Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, United Kingdom
    Pediatr Infect Dis J 31:616-22. 2012
    ..Recent data have demonstrated that 2 of the 3 MCC vaccines showed potential for use as a single priming dose in infancy...
  2. pmc Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, P O Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom
    Clin Vaccine Immunol 18:1492-6. 2011
    ....
  3. pmc Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults
    H Findlow
    Vaccine Evaluation Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, P O Box 209, Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom
    Clin Vaccine Immunol 18:424-9. 2011
    ....
  4. pmc Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults
    H Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, Clinical Sciences Building, Manchester Royal Infirmary, Manchester, UK
    Clin Vaccine Immunol 16:969-77. 2009
    ..The two OPA methods correlated weakly and achieved only a low correlation with the other immunoassays. The correlation between hSBA and group A-specific IgG was higher for the PsA-TT group than for the PsA/C group...
  5. pmc Competitive inhibition flow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular polysaccharide
    H Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, P O Box 209, Clinical Sciences Building, CSB2, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, United Kingdom
    Clin Vaccine Immunol 16:222-9. 2009
    ..The assay developed here is well suited to large-scale epidemiologic studies because the assay is simple, robust, and rapid and utilizes readily available resources...
  6. ncbi request reprint Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, Manchester Royal Infirmary, Manchester, M13 9WZ, UK
    J Infect Dis 195:1071-7. 2007
    ..The presence of cnl meningococci that can escape serum killing and cause invasive disease is of concern for future vaccination strategies and should promote rigorous surveillance of cnl meningococcal disease...
  7. pmc Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine
    Helen Findlow
    Vaccine Evaluation Unit, Health Protection Agency North West, P O Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester, M13 9WZ, United Kingdom
    Clin Vaccine Immunol 13:507-10. 2006
    ..Further studies on IgG subclasses following meningococcal polysaccharide and conjugate vaccination are needed...
  8. pmc Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom
    Jo Southern
    Immunisation Department, Centre for Infections, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Clin Vaccine Immunol 16:194-9. 2009
    ..This study demonstrates that NeisVac-C and Menjugate generate good immunogenicity after the first dose at 2 months of age when coadministered with PCV7 and Pediacel and merit further investigation in single-dose priming strategies...
  9. pmc Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine
    Ray Borrow
    Vaccine Evaluation Unit, Health Protection Agency, Manchester Medical Microbiology Partnership, P O Box 209, Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom
    Clin Vaccine Immunol 17:154-9. 2010
    ....
  10. pmc Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age
    Elizabeth Miller
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Clin Vaccine Immunol 18:367-72. 2011
    ..The United Kingdom infant immunization schedule now recommends that these three vaccines may be offered at one visit at between 12 and 13 months of age...
  11. ncbi request reprint Meningococcal carriage and immunity in western Burkina Faso, 2003
    Seydou Yaro
    Centre Muraz, Bobo Dioulasso, Burkina Faso
    Vaccine 25:A42-6. 2007
    ..A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa...
  12. ncbi request reprint Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
    Nilima Kshirsagar
    Seth G S Medical College and KEM Hospital Parel, Mumbai, India
    Vaccine 25:A101-7. 2007
    ..This opens the prospective for further development and licensure of this vaccine to eliminate epidemic meningitis in sub-Saharan Africa...
  13. ncbi request reprint Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135
    Amina Amadou Hamidou
    centre de recherche médicale et sanitaire, Réseau International des Instituts Pasteur, BP 10887, Niamey, Niger
    Microbes Infect 8:2098-104. 2006
    ..In May, 45.5% of them had specific IgG > or = 2 microg/ml vs. 5.3% among non-carriers...